ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $671,608 | -3.0% | 187,600 | 0.0% | 0.00% | – |
| Q2 2023 | $692,244 | +88.1% | 187,600 | +68.7% | 0.00% | – |
| Q1 2023 | $368,072 | -14.7% | 111,200 | 0.0% | 0.00% | – |
| Q4 2022 | $431,456 | +285.2% | 111,200 | +141.7% | 0.00% | – |
| Q3 2022 | $112,000 | +124.0% | 46,000 | +82.5% | 0.00% | – |
| Q2 2022 | $50,000 | -65.3% | 25,200 | -69.3% | 0.00% | – |
| Q1 2021 | $144,000 | -10.6% | 82,000 | -0.8% | 0.00% | – |
| Q4 2020 | $161,000 | -37.8% | 82,700 | -23.8% | 0.00% | – |
| Q3 2020 | $259,000 | -52.2% | 108,500 | -41.3% | 0.00% | – |
| Q2 2020 | $542,000 | +107.7% | 184,900 | +104.3% | 0.00% | – |
| Q1 2020 | $261,000 | +177.7% | 90,500 | +283.5% | 0.00% | – |
| Q4 2019 | $94,000 | -10.5% | 23,600 | 0.0% | 0.00% | – |
| Q3 2019 | $105,000 | +15.4% | 23,600 | 0.0% | 0.00% | – |
| Q2 2019 | $91,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |